NASDAQ: IMNNImunon Inc Stock Ownership - Who owns Imunon?
Insider buying vs selling
Have Imunon Inc insiders been buying or selling?
Buy
Sell
| Name | Role | Date | Shares | Price | Value |
|---|---|---|---|---|---|
| Michael H. Tardugno | Chair | 2026-09-11 | 5,824 | $1.47 | $8.56kBuy |
| Douglas Vincent Faller | Med | 2026-09-11 | 4,211 | $1.47 | $6.19kBuy |
| Stacy Lindborg | CEO;Pres | 2026-09-11 | 5,504 | $1.47 | $8.09kBuy |
| Susan Eylward | CLO;Sec | 2026-08-31 | 2,525 | $1.56 | $3.95kSell |
| Susan Eylward | CLO;Sec | 2026-08-28 | 2,525 | $1.60 | $4.04kBuy |
| Michael H. Tardugno | Chair | 2026-08-28 | 7,371 | $1.60 | $11.79kBuy |
| Douglas Vincent Faller | Med | 2026-08-28 | 3,626 | $1.60 | $5.80kBuy |
| Stacy Lindborg | CEO;Pres | 2026-08-28 | 6,822 | $1.60 | $10.92kBuy |
| Susan Eylward | CLO;Sec | 2026-08-17 | 2,449 | $1.63 | $3.99kSell |
| Stacy Lindborg | CEO;Pres | 2026-08-14 | 6,615 | $1.65 | $10.91kBuy |
IMNN insiders have bought more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership
Be the first to know when IMNN insiders and whales buy or sell their stock.
IMNN Shareholders
What type of owners hold Imunon Inc stock?
Institutional
Insider
Retail
| Name | Hold | Shares | Value | Type |
|---|---|---|---|---|
| Augustine Y. Cheung | 94.14% | 5,282,676 | $7.18M | Insider |
| Egwu Inc Fka Egen Inc | 43.16% | 2,421,867 | $3.29M | Insider |
| Max Link | 6.78% | 380,385 | $517.32k | Insider |
| Claude Tihon | 2.64% | 148,346 | $201.75k | Insider |
| Stacy Lindborg | 1.91% | 107,136 | $145.70k | Insider |
| Michael H. Tardugno | 1.87% | 104,943 | $142.72k | Insider |
| Frederick J. Fritz | 0.81% | 45,581 | $61.99k | Insider |
| Alberto R. Martinez Jr. | 0.80% | 45,000 | $61.20k | Insider |
| Gary W. Pace | 0.77% | 43,356 | $58.96k | Insider |
| Douglas Vincent Faller | 0.74% | 41,288 | $56.15k | Insider |
IMNN vs Biotech Stocks
Imunon Stock Ownership FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.